menu
    • menu

    Company profile for Viatris

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to co...
    In November 2020, Viatris was formed through the combination of Mylan and Upjohn, with a mission of empowering people worldwide to live healthier at every stage of life. Viatris (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ViatrisUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Robert J. Coury Global Center 1000 Mylan Blvd. Canonsburg, PA 15317
    Telephone
    Telephone
    +1.724.514.1800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.viatris.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/viatris/
    youtube
    YouTube
    Twitter
    Twitter
    https://twitter.com/viatrisinc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    This week, SpeakPharma interviews four senior executives of LGM Pharma — Shailesh Vengurlekar (Senior VP, Quality and Regulatory Affairs), Deepak Thassu (Senior VP, R&D and Regulatory Submission), Selwyn Lustman (Senior VP, Global Sourcing and Procurement), and Mike Stenberg (VP, Business Development). The four VPs talk about expansion in manufacturing capabilities of the Florida-based contract development and manufacturing organization (CDMO), expertise that makes LGM a strong partner and the criteria it adopts while selecting its suppliers.  HIGHLIGHTS// expansion in manufacturing capabilities/ expertise that makes LGM a strong partner/ criteria for selecting its suppliers LGM Pharma recently invested heavily in expanding its CDMO capabilities by 50 percent. Can you share why offering standalone analytical testing services is important to LGM Pharma’s growth strategy? How does it benefit your clients? Vengurlekar: This recent expansion in CDMO capabilities is part of LGM Pharma’s growth strategy that lays importance on diversification. One key area of this diversification is the offering of standalone Analytical Testing Services (ATS). This service plays a crucial role in supporting our clients by providing them with greater flexibility and reliability. LGM Pharma is already a well-established leader in the API supply chain. We have now identified a significant need in the market and are now serving compounding pharmacies, including 503A and 503B facilities. These pharmacies not only require high-quality, GMP-compliant APIs, but also need a trusted, compliant, and capable laboratory to analyze both their APIs and compounded products. Recognizing this opportunity to further support our clients, LGM Pharma has expanded into ATS. We have witnessed tremendous growth since we’ve launched these services. By offering ATS under a separate legal entity — LGM Pharma Solutions — we are able to provide an additional layer of flexibility to our clients. This structure eliminates any conflict of interest. While LGM Pharma LLC handles API supply, LGM Pharma Solutions focuses on delivering top-tier ATS, all under the same LGM Pharma umbrella. This setup enhances trust and allows our clients to work with us more seamlessly. HIGHLIGHTS// diversified into standalone ATS/ well-established leader in API supply chain/ serving compounding pharmacies/ offering APIs and ATS under different legal entities. While suppositories offer clear advantages for certain medications, can you describe how LGM Pharma plans to leverage its expertise in this area to address specific unmet needs in the growing women’s health market? Thassu: We’re taking a dual approach to enhance both our R&D and manufacturing capabilities. First, we’ve introduced a new semi-automatic machine that allows us to produce smaller batches more efficiently. This is particularly important for the suppository segment, where demand doesn’t require large-scale production. The new system enables quicker adjustments to the manufacturing process, providing us with greater flexibility of producing small batches. Second, many of the materials we handle in the women’s health sector are sensitive to heat, light, and oxygen. To address this, we’re upgrading our facility to accommodate these specialized requirements. This ensures we can develop and manufacture products while maintaining the integrity of heat-, light-, and oxygen-sensitive ingredients. Additionally, we’re working closely with clients to prepare for various technical challenges. Whether it’s processing homeopathic ingredients or handling delicate fermentation-based materials, which are highly sensitive to both light and heat, our team has upgraded its skills and equipment to manage these complexities. From technology advancements in manufacturing to specialized handling conditions and improved technical expertise, we’ve made significant strides to ensure we can meet the evolving needs of our clients and their products. HIGHLIGHTS// dual approach to enhance R&D and manufacturing capabilities/ upgrading facilities to accommodate specialized requirements/ working with clients to address challenges. The pandemic underscored supply chain problems. Can you detail the specific criteria LGM Pharma uses while selecting suppliers for its manufacturing processes? Lustman: LGM looks at many facets of a manufacturer before proceeding to approve them for a specific project. We start by checking their regulatory history with the US Food and Drug Administration (FDA) and other authorities. We try to find out if they have received any warning letters. What is their inspection history? Have they received NAIs (no action indicated) and VAIs (voluntary action indicated)? We further investigate the company’s overall business status — we need to know that they are a stable partner to work with in the long term. Manufacturers are then assessed for their overall technology and the number of employees working in various fields, such as R&D, quality control, quality assurance, regulatory affairs, manufacturing, and the educational levels of these employees. Once we have established that the manufacturer is a potential partner, we check their status for a particular project. We look at their advantages, and whether they have a non-infringing route of synthesis (ROS) that will allow early launch. Are they developing a second process that will be more competitive in pricing? And, does the manufacturer have the necessary capacity and/or spare capacity for the project that we are assessing? We need to know whether the drug master file (DMF) has been registered, the current batch size, and the potential for increase in batch size. Pricing is a key indicator — we need to know whether the pricing of the manufacturer is competitive or not, and if the manufacturer will be able to compete in the future as the project matures. LGM always assesses for quality, price, and delivery. Goods must be of the correct quality, at the right price, with delivery time as desired, in order to meet commercial needs. HIGHLIGHTS// investigate various facets of manufacturer before approving them for a project/ look at advantages, non-infringing ROS/ assess for quality, price, delivery Can you highlight specific capabilities and experiences LGM Pharma possesses that make it a strong partner for companies developing antibody-drug-conjugates (ADCs)? Stenberg: ADCs are often peptides linked with small molecules. However, they may also be peptides linked with oligonucleotides. Regardless, LGM can help manage the supply chain associated with the components that are used in the conjugation of the ADC. LGM has extensive experience, and an extensive network around sourcing and managing the supply chain associated with ADC components. LGM’s experience and capabilities extend to sourcing peptides, small molecules or oligonucleotides used in the conjugation process. Additionally, given our deep relationships in the supply chain aspect of this process, LGM may also be able to identify partners who can help with the conjugation process itself. HIGHLIGHTS// extensive experience, network around sourcing, managing supply chain associated with ADC components / identify partners that can help with conjugation process

    Impressions: 489

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients

    #SpeakPharma With LGM Pharma
    09 Nov 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    This year has seen pivotal advancements in medical innovation. The US Food and Drug Administration (FDA) has approved several groundbreaking therapies that promise to transform patient care across multiple therapeutic areas.Some of the therapies approved have revolutionary delivery mechanisms, while others are first-in-class treatments for previously unaddressed conditions. This week, PharmaCompass brings you a compilation of new pathbreaking approvals of 2024, including advancements in neurology, chronic conditions, mental health conditions, and innovative solutions for various other ailments.Lilly, Alpha Cognition, BMS transform neurological care with new Alzheimer’s, schizophrenia drugsThe neurological treatment landscape saw several major breakthroughs in 2024, particularly in the treatment of Alzheimer’s disease (AD). Eli Lilly’s Kisunla represents a significant advancement in treating early, symptomatic AD. Following decades of failed efforts, Kisunla’s approval, along with that of Eisai-Biogen’s Leqembi last year, marks a turning point in addressing AD.The drug works by targeting and clearing beta amyloid plaque from the brain, thereby attacking the disease’s underlying pathology, rather than just managing symptoms. Administered as an infusion every four weeks, Kisunla’s Medicare coverage makes it accessible to patients in the US who desperately need new treatment options. Alpha Cognition’s Zunveyl emerged as a promising new oral treatment for mild-to-moderate Alzheimer’s-related dementia. Only the second oral AD treatment approved by the FDA in over a decade, Zunveyl is a prodrug, or a biologically inactive compound that can be metabolized by the body to produce a drug. It remains inactive as it passes through the stomach and enhances cholinergic function in the brain.Perhaps one of the most exciting breakthroughs of 2024 was Bristol-Myers Squibb’s Cobenfy. This revolutionary antipsychotic medication for schizophrenia represents the first novel approach to treatment since the 1950s. Unlike traditional antipsychotics that target dopamine receptors, Cobenfy works through cholinergic receptors, offering new hope to patients who struggle with the side effects of conventional treatments.Traditional antipsychotics have been associated with several mild and serious side effects such as weight gain, feeling unmotivated and sluggish, high rates of cardiac disease, and even early death. Cobenfy’s innovative mechanism of action has generated excitement in the medical community. Experts project Cobenfy to bring in US$ 7.5 billion in peak annual sales, thereby validating BMS’ recent, US$ 14-billion acquisition of Karuna Therapeutics.Verona, Sanofi’s drugs revolutionize COPD care; Madrigal’s Rezdiffra offers hope to MASH patients The landscape of chronic obstructive pulmonary disease (COPD) treatment saw remarkable advances in 2024. Verona Pharma’s Ohtuvayre brings the first new mechanism of action in over two decades for COPD treatment. This dual-action, inhaled medication serves as both a bronchodilator and an anti-inflammatory agent, offering a comprehensive approach to symptom management.Adding to this progress, Sanofi and Regeneron’s Dupixent achieved a historic milestone by becoming the first biologic approved for treating COPD. Dupixent is Sanofi’s best-selling drug. It is poised to cross over € 21 billion (US$ 23.5 billion) in sales by 2030, with COPD likely to contribute US$ 2.9 billion, predict analysts. Over 390 million people are living with COPD worldwide.In the field of liver disease, Madrigal Pharmaceuticals’ Rezdiffra became the first FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring. This approval represents a breakthrough in a field that has been notorious for being a graveyard for failed programs. Rezdiffra offers hope to patients with this common liver condition, which primarily affects those with obesity or type 2 diabetes. The American Liver Foundation has termed this approval a “game-changing” moment in hepatology.For the rare disease community, Ipsen’s Iqirvo emerged as the first new medicine approved in nearly a decade for primary biliary cholangitis (PBC). This first-in-class peroxisome proliferator-activated receptor (PPAR) agonist offers new hope for the approximately 100,000 Americans affected by this condition, particularly women aged 30 to 60 years.A significant breakthrough for patients with hypoparathyroidism came with the approval of Ascendis’ Yorvipath, making it the only treatment for hypoparathyroidism in adults. By directly addressing the underlying hormone deficiency, Yorvipath helps stabilize calcium levels in the blood, reducing the treatment burden associated with managing symptoms through calcium and vitamin D supplements alone.In the realm of pulmonary medicine, Merck’s Winrevair emerged as the first new therapy for pulmonary arterial hypertension (PAH) in over a decade. As the first approved activin-signaling inhibitor therapy, Winrevair represents a novel approach to treating this rare but severe condition that doctors call a “ticking time bomb”. The drug is the first treatment that targets the underlying cause of the lung condition, which typically leads to death within a decade of diagnosis.ARS Pharma launches nasal spray alternative to EpiPen, Eicos introduces med for severe frostbiteLeading the charge in innovative drug delivery is ARS Pharma’s Neffy, the first-ever nasal spray alternative to the EpiPen for treating severe allergic reactions. This groundbreaking advancement represents the first major innovation in anaphylaxis treatment in over a decade. For children and individuals with needle phobia, this nasal spray format addresses one of the most significant barriers to timely treatment of allergic emergencies. Speaking of emergency medicine, Eicos Sciences’ Aurlumyn made history as the first FDA-approved treatment for severe frostbite. This approval fills a critical gap in emergency care, offering a medical intervention that could prevent the need for amputation in severe cases.The cardiovascular space saw its first oral anti-hypertensive therapy that works through a new therapeutic pathway in almost 40 years. Idorsia’s Tryvio is a treatment for hypertension that offers new hope to patients whose blood pressure remains inadequately controlled on existing medications. Idorsia expects millions of patients to benefit from it.Our view This year, the pharmaceutical industry has taken a remarkable leap forward by addressing some of healthcare’s most challenging conditions. Treatments like BMS’ Cobenfy for schizophrenia and Madrigal’s Rezdiffra for MASH demonstrate the industry’s growing ability to translate science into practical therapies. With the growing use of artificial intelligence in the drug industry, we hope that these approvals are just a precursor to a bevy of pathbreaking therapies in the years to come. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 680

    https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments

    #Phispers by PHARMACOMPASS
    14 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Safecor Health Acquires Viatris' US Unit-Dose Packaging Business
    Safecor Health Acquires Viatris' US Unit-Dose Packaging Business

    18 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/safecor-health-announces-acquisition-of-viatris-us-unit-dose-packaging-business-302306394.html

    PR NEWSWIRE
    18 Nov 2024
    Share Share
    Viatris Reports Q3 Financial Results for 2024
    Viatris Reports Q3 Financial Results for 2024

    07 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-reports-third-quarter-financial-results-for-2024-302298689.html

    PR NEWSWIRE
    07 Nov 2024
    Share Share
    Viatris Announces Q32024 Dividend
    Viatris Announces Q32024 Dividend

    05 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-announces-third-quarter-2024-dividend-302296180.html

    PR NEWSWIRE
    05 Nov 2024
    Share Share
    Viatris Named to Forbes' World's Top Companies for Women 2024 List
    Viatris Named to Forbes' World's Top Companies for Women 2024 List

    29 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-named-to-forbes-worlds-top-companies-for-women-2024-list-302290273.html

    PR NEWSWIRE
    29 Oct 2024
    Share Share
    Viatris To Participate In UBS And Jefferies Healthcare Conferences
    Viatris To Participate In UBS And Jefferies Healthcare Conferences

    29 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-to-participate-in-the-ubs-global-healthcare-conference-and-jefferies-london-healthcare-conference-302290043.html

    PR NEWSWIRE
    29 Oct 2024
    Share Share
    Lexicon Announces Licensing Agreement With Viatris For Sotagliflozin
    Lexicon Announces Licensing Agreement With Viatris For Sotagliflozin

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2964507/0/en/Lexicon-Announces-Exclusive-Licensing-Agreement-With-Viatris-for-Sotagliflozin-in-All-Markets-Outside-of-the-U-S-and-Europe.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    (s)-pregabalin

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    02

    Abacavir Sulfate Usp

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    Abacavir Sulfate Usp

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris

    GDUFA

    DMF Review : Complete

    Rev. Date : 2017-06-16

    Pay. Date : 2017-05-11

    DMF Number : 18229

    Submission : 2005-03-30

    Status : Active

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Abaloparatide

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    04

    Abametapir

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    05

    Acyclovir Usp

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    Acyclovir Usp

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris

    GDUFA

    DMF Review : Complete

    Rev. Date : 2012-12-26

    Pay. Date : 2012-11-19

    DMF Number : 13277

    Submission : 1998-10-22

    Status : Active

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Adefovir Dipivoxil

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    07

    Alendronate Sodium Usp (trihydrate)

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    08

    Allopurinol Usp

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    09

    Almotriptan Malate Usp

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow

    Almotriptan Malate Usp

    U.S.A
    arrow
    Pharmtech & Ingredients
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris

    GDUFA

    DMF Review : Complete

    Rev. Date : 2013-02-08

    Pay. Date : 2012-11-06

    DMF Number : 20424

    Submission : 2007-03-22

    Status : Active

    Type : II

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Alprazolam Usp

    U.S.A
    Pharmtech & Ingredients
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris Licenses Sotagliflozin from Lexicon Outside U.S. and Europe

    Details:

    Under the license agreement, Viatris will acquire the rights to Inpefa (sotagliflozin) from Lexicon for the treatment of heart failure and type 2 diabetes in all markets outside the U.S. and Europe.


    Lead Product(s): Sotagliflozin

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Inpefa

    Study Phase: ApprovedProduct Type: Small molecule

    Recipient: Lexicon pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: $25.0 million

    Deal Type: Licensing Agreement October 16, 2024

    blank

    01

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Sotagliflozin

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved

    Recipient : Lexicon pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Viatris Licenses Sotagliflozin from Lexicon Outside U.S. and Europe

    Details : Under the license agreement, Viatris will acquire the rights to Inpefa (sotagliflozin) from Lexicon for the treatment of heart failure and type 2 diabetes in all markets outside the U.S. and Europe.

    Brand Name : Inpefa

    Molecule Type : Small molecule

    Upfront Cash : $25.0 million

    October 16, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris Announces Positive Results from EFFEXOR Study in GAD Patients

    Details:

    Effexor (Venlafaxine HCl) is a serotonin and norepinephrine reuptake inhibitor. It is indicated for the treatment of Generalized Anxiety Disorder.


    Lead Product(s): Venlafaxine Hydrochloride

    Therapeutic Area: Psychiatry/Psychology Brand Name: Effexor

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 09, 2024

    blank

    02

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venlafaxine Hydrochloride

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Viatris Announces Positive Results from EFFEXOR Study in GAD Patients

    Details : Effexor (Venlafaxine HCl) is a serotonin and norepinephrine reuptake inhibitor. It is indicated for the treatment of Generalized Anxiety Disorder.

    Brand Name : Effexor

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    October 09, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Gilead Partners with Six Generics For Lenacapavir Access in HIV Prevention

    Details:

    The agreement aims to make and sell generic lenacapavir, subject to required regulatory approvals, in 120 high-incidence, resource-limited countries for HIV prevention.


    Lead Product(s): Lenacapavir

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Sunlenca

    Study Phase: Phase IIIProduct Type: Small molecule

    Recipient: Gilead Sciences

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement October 02, 2024

    blank

    03

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lenacapavir

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Phase III

    Recipient : Gilead Sciences

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Gilead Partners with Six Generics For Lenacapavir Access in HIV Prevention

    Details : The agreement aims to make and sell generic lenacapavir, subject to required regulatory approvals, in 120 high-incidence, resource-limited countries for HIV prevention.

    Brand Name : Sunlenca

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    October 02, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Calliditas’ Partner Viatris Pharma Starts Phase III Trial with Nefecon in Japan

    Details:

    Nefecon is an oral, delayed release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity, indicated for IgA nephropathy.


    Lead Product(s): Budesonide

    Therapeutic Area: Nephrology Brand Name: Nefecon

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 05, 2024

    blank

    04

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Budesonide

    Therapeutic Area : Nephrology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Calliditas’ Partner Viatris Pharma Starts Phase III Trial with Nefecon in Japan

    Details : Nefecon is an oral, delayed release formulation of budesonide, a corticosteroid with potent glucocorticoid activity and weak mineralocorticoid activity, indicated for IgA nephropathy.

    Brand Name : Nefecon

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    July 05, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris Launches RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in The U.S.

    Details:

    Ryzumvi (phentolamine mesylate) is an alpha adrenergic blocker indicated for treating pharmacologically-induced mydriasis produced by adrenergic agonists or parasympatholytic agents like tropicamide.


    Lead Product(s): Phentolamine Mesylate

    Therapeutic Area: Ophthalmology Brand Name: Ryzumvi

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable April 01, 2024

    blank

    05

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Phentolamine Mesylate

    Therapeutic Area : Ophthalmology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Viatris Launches RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in The U.S.

    Details : Ryzumvi (phentolamine mesylate) is an alpha adrenergic blocker indicated for treating pharmacologically-induced mydriasis produced by adrenergic agonists or parasympatholytic agents like tropicamide.

    Brand Name : Ryzumvi

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    April 01, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Idorsia and Viatris Close Global Research Collaboration Transaction

    Details:

    The collaboration focuses on the clinical development & commercialization of ACT-246475 (selatogrel), a reversible, highly selective P2Y12 inhibitor for treating Acute Myocardial Infarction.


    Lead Product(s): Selatogrel

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: ACT-246475

    Study Phase: Phase IIIProduct Type: Small molecule

    Recipient: Idorsia Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: $350.0 million

    Deal Type: Collaboration March 18, 2024

    blank

    06

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Selatogrel

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Phase III

    Recipient : Idorsia Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Idorsia and Viatris Close Global Research Collaboration Transaction

    Details : The collaboration focuses on the clinical development & commercialization of ACT-246475 (selatogrel), a reversible, highly selective P2Y12 inhibitor for treating Acute Myocardial Infarction.

    Brand Name : ACT-246475

    Molecule Type : Small molecule

    Upfront Cash : $350.0 million

    March 18, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Idorsia and Viatris Enter Into a Significant Global Research and Development Collaboration

    Details:

    The collaboration focuses on the clinical development and commercialization of ACT-246475 (selatogrel), a fast-acting, selective P2Y12 inhibitor for treating Acute Myocardial Infarction.


    Lead Product(s): Selatogrel

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: ACT-246475

    Study Phase: Phase IIIProduct Type: Small molecule

    Recipient: Idorsia Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration February 27, 2024

    blank

    07

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Selatogrel

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Phase III

    Recipient : Idorsia Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Idorsia and Viatris Enter Into a Significant Global Research and Development Collaboration

    Details : The collaboration focuses on the clinical development and commercialization of ACT-246475 (selatogrel), a fast-acting, selective P2Y12 inhibitor for treating Acute Myocardial Infarction.

    Brand Name : ACT-246475

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    February 27, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic O...

    Details:

    YUPELRI® (revefenacin) inhalation solution is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease.


    Lead Product(s): Revefenacin

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Yupelri

    Study Phase: Phase IIIProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable November 13, 2023

    blank

    08

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Revefenacin

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) P...

    Details : YUPELRI® (revefenacin) inhalation solution is an anticholinergic indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease.

    Brand Name : Yupelri

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    November 13, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® from Viatris, Inc.

    Details:

    Through the agreement, Viatris divests its rights to women's healthcare products Duphaston (dydrogesterone) and Femoston (estradiol/dydrogesterone) to Theramex.


    Lead Product(s): Dydrogesterone

    Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Duphaston

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Theramex

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Divestment October 10, 2023

    blank

    09

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Dydrogesterone

    Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Theramex

    Deal Size : Undisclosed

    Deal Type : Divestment

    DEALS_DEV arrow-down

    Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® from Via...

    Details : Through the agreement, Viatris divests its rights to women's healthcare products Duphaston (dydrogesterone) and Femoston (estradiol/dydrogesterone) to Theramex.

    Brand Name : Duphaston

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    October 10, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Est...

    Details:

    Through the agreement, Viatris divests its rights to women's healthcare products Duphaston (dydrogesterone) and Femoston (sstradiol/dydrogesterone) to Theramex and its Women's Healthcare business, primarily related to oral and injectable contraceptives, to Insud Pharma.


    Lead Product(s): Dydrogesterone

    Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Duphaston

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Theramex

    Deal Size: $3,370.0 million Upfront Cash: Undisclosed

    Deal Type: Divestment October 01, 2023

    blank

    10

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed

    Viatris

    U.S.A
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Dydrogesterone

    Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Theramex

    Deal Size : $3,370.0 million

    Deal Type : Divestment

    DEALS_DEV arrow-down

    Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Ori...

    Details : Through the agreement, Viatris divests its rights to women's healthcare products Duphaston (dydrogesterone) and Femoston (sstradiol/dydrogesterone) to Theramex and its Women's Healthcare business, primarily related to oral and injectable contraceptives, ...

    Brand Name : Duphaston

    Molecule Type : Small molecule

    Upfront Cash : Undisclosed

    October 01, 2023

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Viatris and get a quotation

    Viatris is a supplier offers 391 products (APIs, Excipients or Intermediates).

    Find a price of Aciclovir bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Febuxostat bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Irbesartan bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Itraconazole bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Lansoprazole bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Rivaroxaban bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Rizatriptan Benzoate bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Rosuvastatin Calcium bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Valacyclovir Hydrochloride bulk with DMF, JDMF, WC offered by Viatris

    Find a price of Alendronate Sodium bulk with DMF, JDMF offered by Viatris

    Find a price of Allopurinol bulk with DMF, JDMF offered by Viatris

    Find a price of Amlodipine Besylate bulk with CEP, WC offered by Viatris

    Find a price of Atomoxetin Hydrochloride bulk with DMF, JDMF offered by Viatris

    Find a price of Bosentan Hydrate bulk with DMF, JDMF offered by Viatris

    Find a price of Clarithromycin bulk with JDMF, WC offered by Viatris

    Find a price of Eletriptan Hydrobromide bulk with DMF, JDMF offered by Viatris

    Find a price of Lamivudine bulk with DMF, WC offered by Viatris

    Find a price of Lanthanum Carbonate bulk with DMF, JDMF offered by Viatris

    Find a price of Loratadine bulk with JDMF, WC offered by Viatris

    Find a price of Montelukast Sodium bulk with DMF, JDMF offered by Viatris

    Find a price of Olmesartan Medoxomil bulk with DMF, JDMF offered by Viatris

    Find a price of Sertraline Hydrochloride bulk with DMF, JDMF offered by Viatris

    Find a price of Sildenafil Citrate bulk with DMF, JDMF offered by Viatris

    Find a price of Sumatriptan bulk with DMF, JDMF offered by Viatris

    Find a price of Tadalafil bulk with DMF, JDMF offered by Viatris

    Find a price of Valsartan bulk with DMF, JDMF offered by Viatris

    Find a price of Zolpidem Tartrate bulk with DMF, JDMF offered by Viatris

    Find a price of Almotriptan Malate bulk with DMF, WC offered by Viatris

    Find a price of Alprazolam bulk with DMF, WC offered by Viatris

    Find a price of Aripiprazole bulk with DMF, WC offered by Viatris

    Find a price of Armodafinil bulk with DMF, WC offered by Viatris

    Find a price of Blonanserin bulk with JDMF, WC offered by Viatris

    Find a price of Candesartan Cilexetil bulk with DMF, WC offered by Viatris

    Find a price of Cetirizine Dihydrochloride bulk with DMF, WC offered by Viatris

    Find a price of Desloratadine bulk with DMF, WC offered by Viatris

    Find a price of Dexlansoprazole bulk with DMF, WC offered by Viatris

    Find a price of Dipyridamole bulk with DMF offered by Viatris

    Find a price of Efinaconazole bulk with DMF, JDMF offered by Viatris

    Find a price of Empagliflozin bulk with DMF, WC offered by Viatris

    Find a price of Emtricitabine bulk with DMF, WC offered by Viatris

    Find a price of Fluconazole bulk with DMF, WC offered by Viatris

    Find a price of Formoterol Fumarate bulk with DMF offered by Viatris

    Find a price of Losartan Potassium bulk with JDMF offered by Viatris

    Find a price of Lurasidone Hydrochloride bulk with DMF, WC offered by Viatris

    Find a price of Nabumetone bulk with DMF offered by Viatris

    Find a price of Nepafenac bulk with DMF, WC offered by Viatris

    Find a price of Oseltamivir Phosphate bulk with DMF, JDMF offered by Viatris

    Find a price of Paliperidone bulk with DMF, WC offered by Viatris

    Find a price of Paliperidone Palmitate bulk with DMF, WC offered by Viatris

    Find a price of Pioglitazone Hydrochloride bulk with DMF, WC offered by Viatris

    Find a price of Pitavastatin bulk with DMF, JDMF offered by Viatris

    Find a price of Pretomanid bulk with DMF, WC offered by Viatris

    Find a price of Risperidone bulk with DMF, WC offered by Viatris

    Find a price of Ritonavir bulk with DMF offered by Viatris

    Find a price of Telmisartan bulk with DMF, WC offered by Viatris

    Find a price of Tetrabenazine bulk with DMF, WC offered by Viatris

    Find a price of Ticagrelor bulk with DMF, WC offered by Viatris

    Find a price of Tofacitinib Citrate bulk with DMF, JDMF offered by Viatris

    Find a price of Verapamil Hydrochloride bulk with DMF, WC offered by Viatris

    Find a price of Zolmitriptan bulk with DMF, WC offered by Viatris

    Find a price of Abacavir Sulfate bulk with DMF offered by Viatris

    Find a price of Ambrisentan bulk with DMF offered by Viatris

    Find a price of Amlodipine Besylate bulk with CEP offered by Viatris

    Find a price of Atazanavir Sulfate bulk with DMF offered by Viatris

    Find a price of Atorvastatin bulk with DMF offered by Viatris

    Find a price of Atovaquone bulk with DMF offered by Viatris

    Find a price of Azathioprine bulk with DMF offered by Viatris

    Find a price of Baclofen bulk with DMF offered by Viatris

    Find a price of Canagliflozin bulk with DMF offered by Viatris

    Find a price of Capecitabine bulk offered by Viatris

    Find a price of Carvedilol bulk with DMF offered by Viatris

    Find a price of Carvedilol Phosphate bulk with DMF offered by Viatris

    Find a price of Celecoxib bulk with DMF offered by Viatris

    Find a price of Clarithromycin bulk with JDMF offered by Viatris

    Find a price of Clopidogrel bulk offered by Viatris

    Find a price of Clozapine bulk with DMF offered by Viatris

    Find a price of Cobicistat bulk with DMF offered by Viatris

    Find a price of Dacarbazine bulk with DMF offered by Viatris

    Find a price of Darunavir bulk with DMF offered by Viatris

    Find a price of Deferasirox bulk with DMF offered by Viatris

    Find a price of Desmopressin Acetate bulk offered by Viatris

    Find a price of Didanosine bulk with DMF offered by Viatris

    Find a price of Dimethyl Fumarate bulk with DMF offered by Viatris

    Find a price of Dolutegravir Sodium bulk with DMF offered by Viatris

    Find a price of Duloxetine Hydrochloride bulk with DMF offered by Viatris

    Find a price of Efavirenz bulk with DMF offered by Viatris

    Find a price of Emtricitabine bulk with DMF offered by Viatris

    Find a price of Enrofloxacin bulk with DMF offered by Viatris

    Find a price of Epinephrine Bitartrate bulk with DMF offered by Viatris

    Find a price of Escitalopram Oxalate bulk with DMF offered by Viatris

    Find a price of Esomeprazole Magnesium bulk with DMF offered by Viatris

    Find a price of Etravirine bulk with DMF offered by Viatris

    Find a price of Ezetimibe bulk with DMF offered by Viatris

    Find a price of Fingolimod Hydrochloride bulk with DMF offered by Viatris

    Find a price of Fluticasone Propionate bulk offered by Viatris

    Find a price of Fosamprenavir bulk with DMF offered by Viatris

    Find a price of Gabapentin bulk with DMF offered by Viatris

    Find a price of Gatifloxacin bulk with DMF offered by Viatris

    Find a price of Lamivudine bulk with DMF offered by Viatris

    Find a price of Lamotrigine bulk with DMF offered by Viatris

    Find a price of Ledipasvir bulk with DMF offered by Viatris

    Find a price of Lenalidomide bulk with DMF offered by Viatris

    Find a price of Letrozole bulk offered by Viatris

    Find a price of Levetiracetam bulk offered by Viatris

    Find a price of Levofloxacin bulk with DMF offered by Viatris

    Find a price of Levofloxacin Hemihydrate bulk with JDMF offered by Viatris

    Find a price of Linagliptin bulk with DMF offered by Viatris

    Find a price of Lisinopril bulk offered by Viatris

    Find a price of Macitentan bulk with DMF offered by Viatris

    Find a price of Memantine Hydrochloride bulk with DMF offered by Viatris

    Find a price of Milnacipran Hydrochloride bulk with DMF offered by Viatris

    Find a price of Mirtazapine bulk with DMF offered by Viatris

    Find a price of Nadolol bulk with DMF offered by Viatris

    Find a price of Nevirapine bulk with DMF offered by Viatris

    Find a price of Palbociclib bulk with DMF offered by Viatris

    Find a price of Pantoprazole Sodium bulk with DMF offered by Viatris

    Find a price of Paroxetine Hydrochloride bulk with DMF offered by Viatris

    Find a price of Perindopril Erbumine bulk with WC offered by Viatris

    Find a price of Pramipexole Dihydrochloride bulk with DMF offered by Viatris

    Find a price of Prasugrel Hydrochloride bulk with DMF offered by Viatris

    Find a price of Pregabalin bulk with DMF offered by Viatris

    Find a price of Proguanil bulk with DMF offered by Viatris

    Find a price of Propafenone Hydrochloride bulk with WC offered by Viatris

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by Viatris

    Find a price of Quinapril bulk offered by Viatris

    Find a price of Rasagiline Mesylate bulk with DMF offered by Viatris

    Find a price of Risedronate Sodium bulk with DMF offered by Viatris

    Find a price of Roflumilast bulk with DMF offered by Viatris

    Find a price of Rotigotine bulk with DMF offered by Viatris

    Find a price of Salmeterol Xinafoate bulk offered by Viatris

    Find a price of Saxagliptin Hydrochloride bulk with DMF offered by Viatris

    Find a price of Sevelamer Carbonate bulk with DMF offered by Viatris

    Find a price of Sitagliptin Phosphate bulk with DMF offered by Viatris

    Find a price of Sofosbuvir bulk with DMF offered by Viatris

    Find a price of Temazepam bulk with DMF offered by Viatris

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Viatris

    Find a price of Tizanidine HCl bulk with DMF offered by Viatris

    Find a price of Trazodone Hydrochloride bulk with DMF offered by Viatris

    Find a price of Valganciclovir Hydrochloride bulk with DMF offered by Viatris

    Find a price of Varenicline Tartrate bulk with DMF offered by Viatris

    Find a price of Voriconazole bulk with DMF offered by Viatris

    Find a price of Zidovudine bulk with DMF offered by Viatris

    Find a price of Abaloparatide Acetate bulk with DMF offered by Viatris

    Find a price of Adefovir Dipivoxil bulk offered by Viatris

    Find a price of Amlodipine Besylate bulk with DMF offered by Viatris

    Find a price of Apixaban bulk with DMF offered by Viatris

    Find a price of Apremilast bulk with DMF offered by Viatris

    Find a price of Aripiprazole bulk with DMF offered by Viatris

    Find a price of Asenapine Maleate bulk with DMF offered by Viatris

    Find a price of Atenolol bulk offered by Viatris

    Find a price of Atropine Sulfate bulk with DMF offered by Viatris

    Find a price of Azilsartan bulk with JDMF offered by Viatris

    Find a price of Bedaquiline bulk with DMF offered by Viatris

    Find a price of Bictegravir Sodium bulk with DMF offered by Viatris

    Find a price of Bromfenac Sodium bulk with DMF offered by Viatris

    Find a price of Candesartan Cilexetil bulk with WC offered by Viatris

    Find a price of Cetirizine Dihydrochloride bulk with WC offered by Viatris

    Find a price of Cevimeline Hydrochloride bulk with DMF offered by Viatris

    Find a price of Chlorthalidone bulk with DMF offered by Viatris

    Find a price of Ciprofloxacin Hydrochloride bulk offered by Viatris

    Find a price of Citalopram Hydrobromide bulk with DMF offered by Viatris

    Find a price of Citalopram Hydrobromide bulk offered by Viatris

    Find a price of Clindamycin Palmitate bulk offered by Viatris

    Find a price of Clobetasone Butyrate bulk with JDMF offered by Viatris

    Find a price of Clofarabine bulk with DMF offered by Viatris

    Find a price of Colestipol bulk with DMF offered by Viatris

    Find a price of Cyclobenzaprine bulk with WC offered by Viatris

    Find a price of Darunavir Ethanolate bulk with DMF offered by Viatris

    Find a price of Desvenlafaxine Succinate bulk with DMF offered by Viatris

    Find a price of Diflunisal bulk with DMF offered by Viatris

    Find a price of Diphenoxylate Hydrochloride bulk with DMF offered by Viatris

    Find a price of Dofetilide bulk with DMF offered by Viatris

    Find a price of Doravirine bulk with DMF offered by Viatris

    Find a price of Droxidopa bulk with DMF offered by Viatris

    Find a price of DTXSID50185290 bulk with WC offered by Viatris

    Find a price of Efavirenz bulk offered by Viatris

    Find a price of Eletriptan Hydrobromide bulk with DMF offered by Viatris

    Find a price of Elvitegravir bulk with DMF offered by Viatris

    Find a price of Empagliflozin bulk with WC offered by Viatris

    Find a price of Epinephrine bulk with DMF offered by Viatris

    Find a price of Eszopiclone bulk with DMF offered by Viatris

    Find a price of Ethacrynic Acid bulk with DMF offered by Viatris

    Find a price of Febuxostat bulk with WC offered by Viatris

    Find a price of Felbamate bulk with DMF offered by Viatris

    Find a price of Ferric Carboxymaltose bulk with DMF offered by Viatris

    Find a price of Fexofenadine Hydrochloride bulk with DMF offered by Viatris

    Find a price of Fluocytosine bulk with DMF offered by Viatris

    Find a price of Fomepizole bulk with DMF offered by Viatris

    Find a price of Frovatriptan Succinate Hydrate bulk with DMF offered by Viatris

    Find a price of Icatibant Acetate bulk with DMF offered by Viatris

    Find a price of Iron Dextran bulk with DMF offered by Viatris

    Find a price of Iron Sucrose bulk with DMF offered by Viatris

    Find a price of Isosulfan Blue bulk with DMF offered by Viatris

    Find a price of Labetalol Hydrochloride bulk offered by Viatris

    Find a price of Lamivudine bulk offered by Viatris

    Find a price of Lanthanum Carbonate bulk with DMF offered by Viatris

    Find a price of Leuprolide Acetate bulk with DMF offered by Viatris

    Find a price of Lopinavir bulk with DMF offered by Viatris

    Find a price of Lopinavir bulk offered by Viatris

    Find a price of Loratadine bulk with DMF offered by Viatris

    Find a price of Mafenide bulk with DMF offered by Viatris

    Find a price of Mesalazine bulk with DMF offered by Viatris

    Find a price of Miglustat bulk with DMF offered by Viatris

    Find a price of Mirtazapine bulk offered by Viatris

    Find a price of Modafinil bulk with DMF offered by Viatris

    Find a price of Molindone bulk with DMF offered by Viatris

    Find a price of Moxifloxacin Hydrochloride bulk offered by Viatris

    Find a price of Naproxen bulk offered by Viatris

    Find a price of Naproxen Sodium bulk offered by Viatris

    Find a price of Nepafenac bulk with DMF offered by Viatris

    Find a price of Netupitant bulk with DMF offered by Viatris

    Find a price of Nevirapine bulk offered by Viatris

    Find a price of Octreotide Acetate bulk with DMF offered by Viatris

    Find a price of Olsalazine bulk with DMF offered by Viatris

    Find a price of Paliperidone Palmitate bulk with DMF offered by Viatris

    Find a price of Parecoxib Sodium bulk with WC offered by Viatris

    Find a price of Pentosan Polysulfate Sodium bulk with DMF offered by Viatris

    Find a price of Pentostatin bulk with DMF offered by Viatris

    Find a price of Perindopril Arginine bulk with WC offered by Viatris

    Find a price of Phenoxybenzamine HCl bulk with DMF offered by Viatris

    Find a price of Phentolamine Mesylate bulk with DMF offered by Viatris

    Find a price of Pirfenidone bulk with DMF offered by Viatris

    Find a price of Plecanatide bulk with DMF offered by Viatris

    Find a price of Plerixafor bulk with DMF offered by Viatris

    Find a price of Pomalidomide bulk with DMF offered by Viatris

    Find a price of Ponatinib bulk with DMF offered by Viatris

    Find a price of Pregabalin bulk offered by Viatris

    Find a price of Primaquine Diphosphate bulk with DMF offered by Viatris

    Find a price of Pyrazinamide bulk with DMF offered by Viatris

    Find a price of Raltegravir Potassium bulk with DMF offered by Viatris

    Find a price of Regadenoson Monohydrate bulk with DMF offered by Viatris

    Find a price of Rilpivirine Hydrochloride bulk with DMF offered by Viatris

    Find a price of Rivaroxaban bulk with WC offered by Viatris

    Find a price of Rivastigmine bulk with DMF offered by Viatris

    Find a price of Rivastigmine bulk offered by Viatris

    Find a price of Rivastigmine Tartrate bulk offered by Viatris

    Find a price of Sacubitril Sodium bulk with DMF offered by Viatris

    Find a price of Sacubitril-Valsartan bulk with DMF offered by Viatris

    Find a price of Selegiline Hydrochloride bulk with DMF offered by Viatris

    Find a price of Sildenafil Citrate bulk offered by Viatris

    Find a price of Sincalide bulk with DMF offered by Viatris

    Find a price of Sodium ferric gluconate bulk with DMF offered by Viatris

    Find a price of Sodium Nitroprusside bulk with DMF offered by Viatris

    Find a price of Stavudine bulk with DMF offered by Viatris

    Find a price of Stavudine bulk offered by Viatris

    Find a price of Sugammadex Sodium bulk with DMF offered by Viatris

    Find a price of Sulfiram bulk with DMF offered by Viatris

    Find a price of Sunitinib bulk offered by Viatris

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by Viatris

    Find a price of Terbinafine Hydrochloride bulk offered by Viatris

    Find a price of Tetrabenazine bulk with DMF offered by Viatris

    Find a price of Thiotepa bulk offered by Viatris

    Find a price of Tiaprofenic Acid bulk offered by Viatris

    Find a price of Ticagrelor bulk with WC offered by Viatris

    Find a price of Tolmetin Sodium bulk with DMF offered by Viatris

    Find a price of Venlafaxine Hydrochloride bulk with DMF offered by Viatris

    Find a price of Verapamil Hydrochloride bulk with WC offered by Viatris

    Find a price of Vilazodone Hydrochloride bulk with DMF offered by Viatris

    Find a price of Vildagliptin bulk with WC offered by Viatris

    Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Viatris

    Find a price of Zidovudine bulk offered by Viatris

    Find a price of Zileuton bulk with DMF offered by Viatris

    Find a price of Zofenopril Calcium bulk offered by Viatris

    Find a price of Abacavir Sulfate bulk offered by Viatris

    Find a price of Abametapir bulk offered by Viatris

    Find a price of Almotriptan Malate bulk offered by Viatris

    Find a price of Azacitidine bulk offered by Viatris

    Find a price of Azelastine Hydrochloride bulk offered by Viatris

    Find a price of Bicalutamide bulk offered by Viatris

    Find a price of Blonanserin bulk offered by Viatris

    Find a price of Bosentan Hydrate bulk offered by Viatris

    Find a price of Cetirizine Dihydrochloride bulk offered by Viatris

    Find a price of Ciprofloxacin bulk offered by Viatris

    Find a price of Citalopram Hydrochloride bulk offered by Viatris

    Find a price of Clarithromycin bulk offered by Viatris

    Find a price of Cyclobenzaprine bulk offered by Viatris

    Find a price of Daclatasvir bulk offered by Viatris

    Find a price of Darifenacin Hydrobromide bulk offered by Viatris

    Find a price of Desloratadine bulk offered by Viatris

    Find a price of Dexlansoprazole bulk offered by Viatris

    Find a price of Dronedarone Hydrochloride bulk offered by Viatris

    Find a price of Enzalutamide bulk offered by Viatris

    Find a price of Eprosartan Mesylate bulk offered by Viatris

    Find a price of Erlotinib bulk offered by Viatris

    Find a price of Erlotinib Hydrochloride bulk offered by Viatris

    Find a price of Etoricoxib bulk offered by Viatris

    Find a price of Febuxostat bulk offered by Viatris

    Find a price of Fluconazole bulk offered by Viatris

    Find a price of Fludrocortisone Acetate bulk offered by Viatris

    Find a price of Gemcitabine bulk offered by Viatris

    Find a price of Iloperidone bulk offered by Viatris

    Find a price of Imatinib Mesylate bulk offered by Viatris

    Find a price of Indinavir bulk offered by Viatris

    Find a price of Irbesartan bulk offered by Viatris

    Find a price of Itraconazole bulk offered by Viatris

    Find a price of Lansoprazole bulk offered by Viatris

    Find a price of Latanoprost bulk offered by Viatris

    Find a price of Lumefantrine bulk offered by Viatris

    Find a price of Nelfinavir Mesylate bulk offered by Viatris

    Find a price of Nitrofurantoin bulk offered by Viatris

    Find a price of Olanzapine bulk offered by Viatris

    Find a price of Omeprazole Magnesium bulk offered by Viatris

    Find a price of Oxcarbazepine bulk offered by Viatris

    Find a price of Oxybutynin Hydrochloride bulk offered by Viatris

    Find a price of Pantoprazole Sodium bulk offered by Viatris

    Find a price of Pemetrexed Disodium bulk offered by Viatris

    Find a price of Penciclovir bulk offered by Viatris

    Find a price of Piperaquine Phosphate bulk offered by Viatris

    Find a price of Prasugrel bulk offered by Viatris

    Find a price of Propafenone Hydrochloride bulk offered by Viatris

    Find a price of Quetiapine Hemifumarate bulk offered by Viatris

    Find a price of Rabeprazole bulk offered by Viatris

    Find a price of Ritonavir bulk offered by Viatris

    Find a price of Rosiglitazone bulk offered by Viatris

    Find a price of Sevelamer Hydrochloride bulk offered by Viatris

    Find a price of Sibutramine Hydrochloride bulk offered by Viatris

    Find a price of Simvastatin bulk offered by Viatris

    Find a price of Tadalafil bulk offered by Viatris

    Find a price of Tenofovir Disoproxil Fumarate bulk offered by Viatris

    Find a price of Tenofovir Disoproxil Maleate bulk offered by Viatris

    Find a price of Thalidomide bulk offered by Viatris

    Find a price of Tolmetin Sodium Dihydrate bulk offered by Viatris

    Find a price of Tolvaptan bulk offered by Viatris

    Find a price of Trientine Hydrochloride bulk offered by Viatris

    Find a price of Valacyclovir Hydrochloride bulk offered by Viatris

    Find a price of Valsartan bulk offered by Viatris

    Find a price of Velpatasvir bulk offered by Viatris

    Find a price of Vorinostat bulk offered by Viatris

    Find a price of Zoledronic Acid bulk offered by Viatris

    Find a price of Zonisamide bulk offered by Viatris

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ROCKFORD, ILLINOIS. bulk offered by Viatris

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES OF TRIFLUOROTHYMIDINE IN JOBAN, IWAKI-CITY, FUKUSHIMA PREFECTURE, JAPAN. bulk offered by Viatris

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PUERTO RICO. bulk offered by Viatris

    Find a price of Abemaciclib bulk offered by Viatris

    Find a price of Adenine bulk offered by Viatris

    Find a price of Apalutamide bulk offered by Viatris

    Find a price of Avatrombopag Maleate bulk offered by Viatris

    Find a price of Baricitinib bulk offered by Viatris

    Find a price of Betrixaban Maleate bulk offered by Viatris

    Find a price of Bexarotene bulk offered by Viatris

    Find a price of Bilastine bulk offered by Viatris

    Find a price of Bortezomib bulk offered by Viatris

    Find a price of Brexpiprazole bulk offered by Viatris

    Find a price of Brigatinib bulk offered by Viatris

    Find a price of Busulfan bulk offered by Viatris

    Find a price of Carfilzomib bulk offered by Viatris

    Find a price of Cetirizine bulk offered by Viatris

    Find a price of Citalopram bulk offered by Viatris

    Find a price of Dasatinib bulk offered by Viatris

    Find a price of Deutetrabenazine bulk offered by Viatris

    Find a price of Dextromethorphan bulk offered by Viatris

    Find a price of Edoxaban Tosylate bulk offered by Viatris

    Find a price of Eprosartan bulk offered by Viatris

    Find a price of Febantel bulk offered by Viatris

    Find a price of Fondaparinux Sodium bulk offered by Viatris

    Find a price of Frovatriptan bulk offered by Viatris

    Find a price of Garenoxacin bulk offered by Viatris

    Find a price of Ibandronate Sodium bulk offered by Viatris

    Find a price of Ibrutinib bulk offered by Viatris

    Find a price of Idelalisib bulk offered by Viatris

    Find a price of Lanreotide Acetate bulk offered by Viatris

    Find a price of Larotrectinib bulk offered by Viatris

    Find a price of Linaclotide bulk offered by Viatris

    Find a price of Liraglutide bulk offered by Viatris

    Find a price of Lumacaftor bulk offered by Viatris

    Find a price of Maraviroc bulk offered by Viatris

    Find a price of Nintedanib Esylate bulk offered by Viatris

    Find a price of Osimertinib Mesylate bulk offered by Viatris

    Find a price of Ozanimod Hydrochloride bulk offered by Viatris

    Find a price of Procarbazine Hydrochloride bulk offered by Viatris

    Find a price of Regorafenib bulk offered by Viatris

    Find a price of Ribociclib bulk offered by Viatris

    Find a price of Romidepsin bulk offered by Viatris

    Find a price of Roxadustat bulk offered by Viatris

    Find a price of Rucaparib Camsylate bulk offered by Viatris

    Find a price of Sacubitril Sodium bulk offered by Viatris

    Find a price of Safinamide Mesylate bulk offered by Viatris

    Find a price of Saxagliptin bulk offered by Viatris

    Find a price of Selexipag bulk offered by Viatris

    Find a price of Semaglutide bulk offered by Viatris

    Find a price of Sitagliptin Hydrochloride bulk offered by Viatris

    Find a price of Sotagliflozin bulk offered by Viatris

    Find a price of Suvorexant bulk offered by Viatris

    Find a price of Trametinib bulk offered by Viatris

    Find a price of Treprostinil Diolamine bulk offered by Viatris

    Find a price of Trifluridine bulk offered by Viatris

    Find a price of Upadacitinib bulk offered by Viatris

    Find a price of Vadadustat bulk offered by Viatris

    Find a price of Valbenazine Tosylate bulk offered by Viatris

    Find a price of Vardenafil Hydrochloride bulk offered by Viatris

    Find a price of Venetoclax bulk offered by Viatris

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search